FEXOFENADINE HYDROCHLORIDE (CAS 153439-40-8)

Fexofenadine Hydrochloride [Cas No. 153439-40-8] is a non-sedating second generation antihistamine API which is usually used in treatment of seasonal allergic rhinitis and chronic urticaria. Fexofenadine Hydrochloride delivers rapid and targeted relief from allergy symptoms such as itching, runny nose, sneezing as it acts as a selective H1-receptor antagonist.

Fexofenadine Hydrochloride is utilized as oral solid dosage forms for example: tablets, capsules and suspension that helps in providing fast action. It does not cross blood brain barrier and reduces the risk of anticholinergic , sedation and antidopaminergic effects. Fexofenadine Hydrochloride has a high tolerance level and has a good safety profile thus is preferred choice among all types of age group.

Chemox Pharma is a leading manufacturer of Fexofenadine Hydrochloride with its multipurpose ultramodern state-of-the-art facility at Dahej Industrial area of Gujarat, India. Chemox Pharma actively seeks global regulatory approvals and files Drug master files (DMFs). We aim to create high quality products and innovative APIs through continuous R&D following the latest WHO – GMP standards.